BD (NYSE:BDX) today announced the introduction of the Elyra thulium fiber laser (TFL) system for treating kidney stones.
In early May 2026, Becton, Dickinson and Company reported higher quarterly sales of US$4.71 billion but swung to a net loss, raised its full-year adjusted earnings guidance, completed the divestiture ...
Medical Device Network on MSN
BD launches Elyra thulium fiber laser system for kidney stone care
The Elyra TFL system is available in two versions, Elyra and Elyra Plus.
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...
BD (NYSE:BDX) has introduced the Elyra Thulium Fiber Laser System for kidney stone treatment, aiming to improve efficiency and flexibility in urologic procedures. The company also restated a long term ...
Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters. As part of a $10 million investment in 2024, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results